Therapeutic Drug Monitoring · 2020 · 10 citations · 19 references
PharmacyPharmacokineticsPharmacologyDrug ClearancePopulation PharmacokineticsRenal Replacement TherapyContinuous Renal Replacement TherapyPharmacokinetics In Critical IllnessPharmacokinetics Of AntimicrobialsRenal Blood FlowRenal Drug ClearanceContinuous Renal Replacement Therapy ClearanceContinuous Renal Replacement Therapy PharmacokineticsCritically Ill Patient Drug ClearanceDrug Clearance By HemodiafiltrationPharmacokinetics Of Antimicrobial AgentsPharmacokinetics Of Intravenous DrugsSepsis PharmacokineticsVolume Of Distribution Differences
BACKGROUND: Although continuous hemodiafiltration (CHDF) is often performed in critically ill patients during sepsis treatment, the pharmacokinetics of vancomycin (VCM) during CHDF with a polymethylmethacrylate hemofilter (PMMA-CHDF) have not been revealed. In this study, the authors aimed to describe the population pharmacokinetics of VCM in critically ill patients undergoing PMMA-CHDF and clarify its hemofilter clearance (CLhemofilter). METHODS: This single-center, retrospective study enrolled patients who underwent intravenous VCM therapy during PMMA-CHDF at the intensive care unit of Chiba University Hospital between 2008 and 2016. A population analysis was performed, and CLhemofilter was assessed. RESULTS: Twenty-five patients were enrolled. Median body weight (BW) and Sequential Organ Failure Assessment (SOFA) score were 63 kg and 15, respectively. Mean conditions for CHDF were 107.5 ± 18.3 mL/min for blood flow rate and 26.3 ± 6.3 mL/kg/h for effluent flow rate. The mean parameter estimates were distribution volume of the central compartment (V1), 59.1 L; clearance of the central compartment (CL1), 1.35 L/h; distribution volume of the peripheral compartment (V2), 56.1 L; and clearance of the peripheral compartment (CL2), 3.65 L/h. BW and SOFA score were significantly associated with V1 (P < 0.05) and CL1 (P < 0.05), respectively, and were thus selected as covariates in the final model. The estimated dosage of VCM to achieve a target area under the concentration-time curve/minimum inhibitory concentration ≥400 was 27.1 mg/kg for loading and 9.7 mg/kg every 24 hours for maintenance; these dosages were affected by BW and SOFA score. Mean CLhemofilter obtained from 8 patients was 1.35 L/h, which was similar to CL1. CONCLUSIONS: The authors clarified the pharmacokinetics and CLhemofilter of VCM in PMMA-CHDF patients. The PK of VCM in patients undergoing CHDF appeared to vary not only with the CHDF setting and BW but also with SOFA score.
19
David F. Gaieski, Mark E. Mikkelsen, Roger A. Band et al. · Critical Care Medicine · 2010 · 962 citations
Veterinary Medicine, Emergency Medical Services, Emergency Medicine +16